(5-(Prop-1-yn-1-yl)pyridin-3-yl)boronic acid, 95.0%, 1g

Glycylglycine>99.0%(T)25g

5-methyl-1,3,4-oxadiazole-2-thiol, 95.0%, 10g

4-[6-[[6-(1-Butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl ester, 98%, 100mg

2-(4-isopropyl-1,3-thiazol-2-yl)ethanamine, 95.0%, 1g

tert-Butyl 1-methyl-4-oxocyclohexanecarboxylate, 98%, 250mg

Methyl 4-cyano-3-methoxybenzoate, 97%, 1g

5-(4-Hydroxy-3-methoxyphenyl)-4-phenyl-2,4-dihydro-3H-1,2,4-triazole-3-thione, 95.0%, 2g

Methyl 3-amino-3-(4-isopropylphenyl)propanoate hydrochloride, 250mg

(1R,5S)-3-azabicyclo[3.2.1]octane hydrochloride, 95.0%, 250mg

6-Chloro-3,3-dimethyl-1H-pyrrolo[2,3-b]pyridin-2(3H)-one, 95.0%, 100mg

Ethyl 2,4-Dihydroxy-6-methylnicotinate, 98.0%, 500g

Direct displacement pipette MICROMAN® E, 20 to 50 µl, 1 piece